$0.18 0.00 (0%)
12/23/2009 3:59 PM

Neurogen Corp (NASDAQ:NRGN)

CAPS Rating: No stars

A drug discovery & development company focusing on new small molecule drugs to improve the lives of patients suffering from disorders with unmet medical need including insomnia, obesity, pain, Parkinson's disease, Restless Legs Syndrome & depression.

Featured Broker Partners


Advertisement